Trial Profile
A Registry Study to Describe the Implications of Therapeutic Management of Etanercept in Patients With Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer; Wyeth
- 07 Feb 2012 Actual number of patients changed from 500 to 441 as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Mar 2011 Actual initiation date changed from Dec 2008 to Jan 2009 as reported by ClinicalTrials.gov.